Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-25 · accession 0001610717-25-000404 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-11-26 | 2025-11-25 | RVMD | Anders Jack | CFO | M - OptEx | $17.00 | +5,418 | 116.4K | +5% | +$92.1K |
| DT | 2025-11-26 | 2025-11-25 | RVMD | Anders Jack | CFO | S - Sale+OE | $74.00 | -5,418 | 111.0K | -5% | -$400.9K |
| DT | 2025-11-26 | 2025-11-25 | RVMD | Anders Jack | CFO | M - OptEx | $0.00 | -5,418 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-25 | M | A | 5,418 | $17.00 | 116,412 | D | — | — | (F2) Includes 48,275 restricted stock units. |
| 2 | Common | Common Stock | 2025-11-25 | S | D | 5,418 | $74.00 | 110,994 | D | — | — | (F2) Includes 48,275 restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-11-25 | M | D | 5,418 | $0.00 | 0 | D | $17.00 · 2024-02-12 to 2030-02-11 | 5,418 Common Stock |